Acasti Pharma

ACST NASDAQ
1.830
-0.040
-2.14%
After Hours: 1.830 0 0.00% 16:36 08/23 EDT
Open
1.820
Prev Close
1.870
High
1.940
Low
1.810
Volume
922.82K
Avg Vol (3M)
2.09M
52 Week High
2.950
52 Week Low
0.4651
% Turnover
1.09%
Market Cap
155.60M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Acasti Pharma ACST stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Acasti Pharma Inc is a Canada-based biopharmaceutical company. The Company is focused on the research, development and commercialization of prescription drugs using omega 3 fatty acids (OM3s) derived from krill oil. OM3s has clinical evidence of safety and efficacy in lowering triglycerides in patients with hypertriglyceridemia (HTG). The Company's drug candidate is CaPre, an OM3 phospholipid, which is being developed for the treatment of severe hypertriglyceridemia, a condition characterized by abnormally high levels of triglycerides in the bloodstream (over 500 mg/dL) (severe hypertriglyceridemia or severe HTG).
MORE >

Recently

Name
Price
%Change